510(k) K111260
K111260 is an FDA 510(k) premarket notification submitted by Anticancer, Inc. for the device "A/C ENZYMATIC VITAMIN B6 ASSAY". The FDA issued a decision of Substantially Equivalent on July 26, 2012. The device falls under product code CDD (Radioassay, Vitamin B12), a Class II device regulated under 21 CFR 862.1810. Anticancer, Inc. has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 26, 2012
- Date Received
- May 5, 2011
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioassay, Vitamin B12
- Device Class
- Class II
- Regulation Number
- 862.1810
- Review Panel
- CH
- Submission Type